Clinical Trials Browser

Phase 3 × Breast Neoplasms × iniparib × Clear all

NCT00938652 2013-09-19

A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms